MA
EXAS

Modus Advisors’s Exact Sciences EXAS Stock Holding History

Modus Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-856
Closed -$86.9K – 179
2025
Q4 		$86.9K Buy
+856
New +$68.7K 0.02% 149
2025
Q1 		– Sell
-763
Closed -$42.9K – 166
2024
Q4 		$42.9K Buy
+763
New +$47.5K 0.01% 158
2021
Q3 		– Sell
-71
Closed -$9K – 146
2021
Q2 		$9K Buy
+71
New +$8.47K ﹤0.01% 215
2020
Q3 		– Sell
-71
Closed -$6K – 125
2020
Q2 		$6K Buy
+71
New +$5.67K ﹤0.01% 186

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Modus Advisors's EXAS Position: Q1 2026 in Review

Modus Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 856 shares — an estimated $86.9K sold.

Modus Advisors first reported a position in EXAS in Q2 2020 and held it in 4 quarters. The position peaked at $86.9K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Modus Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Modus Advisors sold 856 Exact Sciences shares in Q1 2026, an estimated $86.9K.
  • Modus Advisors first reported a position in Exact Sciences in Q2 2020 and held it in 4 quarters.
  • Modus Advisors's Exact Sciences position peaked at $86.9K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Modus Advisors's 13F filing for Q1 2026, filed 4 May 2026.